Saiph Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$849K Buy
6,717
+5,078
+310% +$669K 0.25% 47
2026
Q1
$228K Sell
1,639
-16
-1% -$2.24K 0.09% 73
2025
Q4
$203K Buy
+1,655
New +$201K 0.07% 70
2025
Q1
Sell
-5,591
Closed -$516K 51
2024
Q4
$516K Buy
5,591
+657
+13% +$59.2K 0.23% 33
2024
Q3
$414K Sell
4,934
-62
-1% -$4.73K 0.19% 33
2024
Q2
$343K Buy
4,996
+231
+5% +$15.4K 0.15% 40
2024
Q1
$349K Buy
4,765
+452
+10% +$34.8K 0.16% 38
2023
Q4
$349K Buy
4,313
+1,202
+39% +$93.5K 0.18% 33
2023
Q3
$233K Sell
3,111
-104
-3% -$8K 0.13% 39
2023
Q2
$248K Sell
3,215
-78
-2% -$6.22K 0.13% 35
2023
Q1
$273K Buy
3,293
+158
+5% +$13.1K 0.16% 34
2022
Q4
$269K Buy
+3,135
New +$248K 0.19% 34

Other funds holding GILD

Saiph Capital's GILD Position: Q2 2026 in Review

Saiph Capital increased its Gilead Sciences (GILD) stake by 310% in Q2 2026, buying an estimated $669K and bringing the position to 6,717 shares worth $849K. The position accounts for 0.25% of the portfolio, ranked #47.

Saiph Capital first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Saiph Capital held 6,717 shares of Gilead Sciences worth $849K as of Q2 2026.
  • Saiph Capital bought 5,078 Gilead Sciences shares in Q2 2026, an estimated $669K.
  • Gilead Sciences made up 0.25% of Saiph Capital's portfolio in Q2 2026, its #47 holding.
  • Saiph Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Saiph Capital's 13F filing for Q2 2026, filed 29 Jul 2026.